全球总体基因体学市场规模、份额、趋势和成长分析报告（2026-2034）

预计总体基因体学市场将从 2025 年的 32 亿美元成长到 2034 年的 102.2 亿美元，2026 年至 2034 年的复合年增长率为 13.78%。

由于次世代定序技术在科学研究和诊断领域的快速应用，全球元基因组市场正经历快速成长。元基因组分析能够直接研究环境和临床检体中的遗传物质，深入了解微生物多样性和疾病机制。人们对微生物组研究和感染疾病监测日益增长的兴趣是推动市场扩张的主要动力。

关键成长要素包括高通量定序平台和生物资讯学工具的技术进步。在农业、环境监测和药物研发等领域的应用不断拓展，进一步扩大了市场范围。此外，研究经费的增加以及学术机构与生技公司之间合作的加强，正在加速总体基因体学领域的创新。

未来几年，随着定序成本的下降和数据分析能力的提升，市场预计将进一步受益。对个人化医疗和基于微生物组的治疗方法的日益关注，有望开闢新的增长途径。新兴经济体对基因组研究基础设施的投资预计将会增加，从而支撑全球总体基因体学市场的持续扩张。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章 全球总体基因体学市场：依产品划分

• 市场分析、洞察与预测
• 试剂盒和试剂
• 定序和数据分析服务
• 软体

第五章：全球宏总体基因体学市场：依技术划分

• 市场分析、洞察与预测
• 霰弹枪定序
• 16S定序
• 全基因测序
• 其他的

第六章 全球宏总体基因体学市场：依工作流程划分

• 市场分析、洞察与预测
• 序列预处理
• 定序
• 数据分析

第七章 全球宏总体基因体学市场：依应用划分

• 市场分析、洞察与预测
• 环境
• 临床诊断
• 药物发现
• 生物技术
• 食品与营养
• 其他的

第八章 全球总体基因体学市场：依地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中东和非洲国家

第九章 竞争情势

• 最新趋势
• 公司分类
• 供应链和销售管道合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第十章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Bio-Rad Laboratories Inc
  • Illumina Inc
  • PerkinElmer Inc
  • Thermo Fisher Scientific Inc
  • Novogene Co. Ltd
  • Promega Corporation
  • QIAGEN NV
  • Takara Bio Inc
  • Oxford Nanopore Technologies Plc
  • F. Hoffmann-La Roche Ltd

The Metagenomics Market size is expected to reach USD 10.22 Billion in 2034 from USD 3.20 Billion (2025) growing at a CAGR of 13.78% during 2026-2034.

The Global Metagenomics Market is witnessing rapid growth due to increasing adoption of next-generation sequencing technologies in research and diagnostics. Metagenomics enables the study of genetic material directly from environmental and clinical samples, offering insights into microbial diversity and disease mechanisms. Rising interest in microbiome research and infectious disease surveillance is significantly driving market expansion.

Major growth drivers include technological advancements in high-throughput sequencing platforms and bioinformatics tools. Expanding applications in agriculture, environmental monitoring, and drug discovery are further broadening the market scope. Additionally, increasing research funding and collaborations between academic institutions and biotechnology companies are accelerating innovation in metagenomics.

In the coming years, the market is expected to benefit from decreasing sequencing costs and improved data analysis capabilities. Growing focus on personalized medicine and microbiome-based therapeutics will likely create new growth avenues. Emerging economies are anticipated to increase investments in genomic research infrastructure, supporting sustained expansion of the global metagenomics market.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Kits & Reagents
• Sequencing & Data Analytics Services
• Software

By Technology

• Shotgun Sequencing
• 16S Sequencing
• Whole Genome Sequencing
• Others

By Workflow

• Pre-sequencing
• Sequencing
• Data Analysis

By Application

• Environmental
• Clinical Diagnostics
• Drug Discovery
• Biotechnology
• Food & Nutrition
• Others

COMPANIES PROFILED

• BioRad Laboratories Inc, Illumina Inc, PerkinElmer Inc, Thermo Fisher Scientific Inc, Novogene Co Ltd, Promega Corporation, QIAGEN NV, Takara Bio Inc, Oxford Nanopore Technologies plc, F HoffmannLa Roche Ltd
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL METAGENOMICS MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Kits & Reagents Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Sequencing & Data Analytics Services Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Software Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL METAGENOMICS MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Technology
• 5.2. Shotgun Sequencing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. 16S Sequencing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Whole Genome Sequencing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL METAGENOMICS MARKET: BY WORKFLOW 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Workflow
• 6.2. Pre-sequencing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Sequencing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Data Analysis Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL METAGENOMICS MARKET: BY APPLICATION 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Application
• 7.2. Environmental Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Clinical Diagnostics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Drug Discovery Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Biotechnology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.6. Food & Nutrition Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.7. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL METAGENOMICS MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Product
  • 8.2.2 By Technology
  • 8.2.3 By Workflow
  • 8.2.4 By Application
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Product
  • 8.3.2 By Technology
  • 8.3.3 By Workflow
  • 8.3.4 By Application
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Product
  • 8.4.2 By Technology
  • 8.4.3 By Workflow
  • 8.4.4 By Application
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Product
  • 8.5.2 By Technology
  • 8.5.3 By Workflow
  • 8.5.4 By Application
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Product
  • 8.6.2 By Technology
  • 8.6.3 By Workflow
  • 8.6.4 By Application
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL METAGENOMICS INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Bio-Rad Laboratories Inc
  • 10.2.2 Illumina Inc
  • 10.2.3 PerkinElmer Inc
  • 10.2.4 Thermo Fisher Scientific Inc
  • 10.2.5 Novogene Co. Ltd
  • 10.2.6 Promega Corporation
  • 10.2.7 QIAGEN N.V
  • 10.2.8 Takara Bio Inc
  • 10.2.9 Oxford Nanopore Technologies Plc
  • 10.2.10 F. Hoffmann-La Roche Ltd